Arena Pharmaceuticals Stock Bullish Momentum With an Over 2% Jump So Far Today
ViaNews Editorial Team
November 19, 2020
Automated market report from our archive (2020-2024), published before source-traceability. How we work

Shares of Arena Pharmaceuticals rose 2.35% to $65.35 at 10:05 EST on Thursday. The Nasdaq Stock Market is sliding 0.82% to $11801.6, on what seems, at the moment, a positive trend trading session on The Nasdaq Stock Market.
Arena Pharmaceuticals's last close was $63.85, below its 52-week high of $90.19.
Arena Pharmaceuticals's sales growth is negative 81.3% for the ongoing quarter and 155.7% for the next. The company's growth estimates for the current quarter and the next is a negative 8% and a positive 4.5%, respectively.
Year-on-year quarterly revenue growth declined by 98.5%, now sitting on 3.28M for the twelve trailing months.
Arena Pharmaceuticals's stock is valued at $65.35 at 10:05 EST, way below its 52-week high of $90.19 and way higher than its 52-week low of $32.95.
Arena Pharmaceuticals's value is way under its 50-day moving average of $79.04 and below its 200-day moving average of $67.43.
Are you or your business in this article?
If something is wrong, out of context or missing, tell us. We correct errors with a dated note, and people named in an article can publish their response under it.
Correct, add context or respond →Not a source? Spotted an error? Report an error
How this story was made
Spotted an error? Use “Correct this article” (bottom right), or select any sentence, to report it or respond to that point.
- Published before we listed source documents with each article.
- Published 19 Nov 2020
- No responses yet from the people or organisations in this story. Are you in this story? Respond on the record ›
- Part of the Via News record, fingerprinted daily so it cannot be quietly rewritten. What that means › · Report an error ›
Categories
ViaNews Editorial Team
Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.
